Title: Prevalence and Spectrum of Bleeding Disorders in Females at Tertiary Care Centre

Authors: Dr Indira Sahu, Dr Suman Ruhela

 DOI: https://dx.doi.org/10.18535/jmscr/v9i12.11

Abstract

Bleeding disorders in females is rare but when present, usually present with menorrhagia, mucocutaneous bleeding or per rectal bleed. We retrospectively analysed the spectrum of bleeding disorders in females referred to our laboratory for the workup of bleeding disorders.

Methodology: Females who were referred to our laboratory for workup of bleeding disorders were asked to fill form enquiring a detailed menstrual, family and significant past history including drug intake history. Samples were collected in Na citrate vacuitaners for testing the coagulation parameters.

Results: Out of 607 patients studied for bleeding disorders we found 10(2.1%) females (age range 3 months-69years) with deranged coagulation profile (Isolated increase in APTT). In 8/10 (80%) factor VIII was found reduced which on futher mixing studies 3 of them showed presence of inhibitors, 3/10 females had reduced vWF level so labelled as vWD, other 2/10 had reduced factor VIII so were labelled as mild Hemophillia. 2/10 (20%) were found to have reduced factor IX level but all three females were less than 6 month of age.

Conclusion: Heavy menstrual bleeding may be the only clinical manifestation of an inherited bleeding disorder in a substantial proportion of women and we suggest that all such patients should be investigated for Underlying hemostatic defects. This will not only help in diagnosis but also in proper management for future hemostatic challenges.

References

  1. Guelcher CJ, Chase J, Pollard D. Women and girls with heavy menstrual bleeding and inherited bleeding disorders: A call to action for the Haemophilia Treatment Centre Nurse. Haemophilia. 2021;27 (Suppl. 3):82–86.
  2. James PD. Women and bleeding disorders: diagnostic challenges. Hematology AM SOC HEMATOL Educ Program; 2020; 2020(1):547-52.
  3. Ma AD, Carrizosa D. Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology Am Soc Hematol Educ Program. 2006:432-7.
  4. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485–9.
  5. Dilley A, Drews C, Miller C et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstetrics Gynaecol 2001; 97: 630–6.
  6. Sramek A, Eikenboom JCJ, Briet E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995; 155: 1409–15.
  7. Lee CA. Women and inherited bleeding disorders. Menstrual issues. Semin Hematol 1999; 36(suppl 4):21–7.
  8. Kadir RA, Aledort LM. Obstetrical and gynaecologicalbleeding: a common presenting symptom. Clin Lab Haematol 2000; 22(supp 1): 12–6.
  9. Edlund M, Blomback M, Von schoult ZB, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 234–8.

Corresponding Author

Dr Indira Sahu